BharatBiotech’s Covaxin is now available for children of age 6+


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴
The Drugs Controller General of India (DCGI) has given BharatBiotech’s Covaxin restricted emergency use authorisation. This vaccine can now be used for children between the ages of 6 to 12.

The Drugs Controller General of India (DCGI) has given BharatBiotech’s Covaxin restricted emergency use authorisation. This vaccine can now be used for children between the ages of 6 to 12. Along with Covaxin, Union Health Minister Mansukh Mandaviya announced the approval of Corbevax and ZyCov-D vaccines for children.

This action is taken on the recommendation of the Subject Expert Committee (SEC) on Covid-19 by the Central Drugs Standard Control Organisation or CDSCO. The SEC had last week received applications from BharatBiotech’s Covaxin (for age group 6 to 12) and from Biological E’s Corbevax (for age 5 to 12).

The SEC gave BharatBiotech the no-objection certificate after a two-month-long deliberation on the topic. The DCGI has also asked BharatBiotech to share their safety data and data on adverse events twice every month for 2 months. After these two months, the vaccine maker can monthly send 1 report for 5 consecutive months. 

In December 2021 the DCGI had given Emergency Use Listing (EUL) to Covaxin to be used for ages 12 to 18. Corbevax on the other hand has been used for the age group 12 to 14. Even Zydus Cadila’s two-dose regimen ZycovD vaccine against Covid-19 has been approved for children over the age of 12 years. ZycovD showed a 66.6% efficacy in the interim analysis during Phase 3 clinical trials. 

The vaccination drive started on March 1st for people above the age of 60 years. A month later, on April 1st, the vaccination drive began for people over the age of 45. From May 1st onwards, a vaccination drive for every adult (18 years of age) began. Next came the age group of 15 to 18, for whom the vaccination phase began on January 3rd.

Tags : #BharatBiotech #Covaxin #vaccination #Children-Vaccination #vaccine #Covid-19 #Corbevax #Zycov-D #UnionHealthMinister #MansukhMandaviya #smitakumar #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026